Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

ProMetic Raises C$26.2M For Peptide Mimetics, rAAT Drug

June 18, 2002

ProMetic Raises C$26.2M For Peptide Mimetics, rAAT Drug

June 18, 2002

Abbott Reports Positive Data From Anti-TNF RA Antibody

June 17, 2002

Abbott Reports Positive Data From Anti-TNF RA Antibody

June 17, 2002

Enanta Financing Nets $18M To Advance 'Drug Morphing'

June 14, 2002

Enanta Financing Nets $18M To Advance 'Drug Morphing'

June 14, 2002

Millennium's Velcade Entering Phase III For Multiple Myeloma

June 13, 2002

Millennium's Velcade Entering Phase III For Multiple Myeloma

June 13, 2002

Favrille Series B Gets $16.9M To Pay For Ongoing Studies

June 12, 2002

Gilead, Anadys Enter Deal For HTP With Viral Target

June 11, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...